Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Moleculin Biotech Inc is a clinical-stage pharmaceutical company with a focus on the treatment of highly resistant cancers and viruses through the development of its drug candidates. The company has three core technologies: Annamycin which is a next-generation anthracycline; Immune/Transcription Mod... Moleculin Biotech Inc is a clinical-stage pharmaceutical company with a focus on the treatment of highly resistant cancers and viruses through the development of its drug candidates. The company has three core technologies: Annamycin which is a next-generation anthracycline; Immune/Transcription Modulators, of which WP1066 is a member; and Metabolism/Glycosylation Inhibitors, of which WP1122 is a member. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.0098 | 0.915887850467 | 1.07 | 1.32 | 0.9945 | 971303 | 1.11586047 | CS |
| 4 | -0.1202 | -10.0166666667 | 1.2 | 1.59 | 0.9412 | 1351517 | 1.19613132 | CS |
| 12 | -0.6602 | -37.9425287356 | 1.74 | 3.6499 | 0.3975 | 6221337 | 1.64037308 | CS |
| 26 | -1.3502 | -55.5637860082 | 2.43 | 3.6499 | 0.3975 | 2808528 | 1.64802381 | CS |
| 52 | -3.8602 | -78.1417004049 | 4.94 | 6.2348 | 0.3975 | 1404023 | 1.67097363 | CS |
| 156 | -25.4702 | -95.9329566855 | 26.55 | 30.75 | 0.3975 | 558969 | 3.58604683 | CS |
| 260 | -9.4202 | -89.7161904762 | 10.5 | 131.7 | 0.3975 | 1117778 | 21.90575057 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
